211 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
Rank Status Study
21 Not yet recruiting MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Conditions: Diabetes;   Hyperlipidemia;   Hypertension;   Cardiovascular Disease
Intervention: Behavioral: CVRS Intervention
22 Recruiting Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
Conditions: Nephrotic Syndrome;   Hyperlipidemia
Intervention: Drug: Pravastatin
23 Not yet recruiting Improving Heart Health in Appalachia
Conditions: Obesity;   Hypertension;   Hyperlipidemia;   Depression
Interventions: Behavioral: patient-centered, culturally appropriate, self-care CVD risk reduction;   Other: Referral to primary care provider for CVD risk management
24 Unknown  Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Condition: Hyperlipidemia
Interventions: Drug: Pitavastatin;   Drug: Atorvastatin
25 Recruiting Endothelial Hyperpolarization in Humans
Condition: Hyperlipidemia
Interventions: Drug: Tetraethylammonium (TEA);   Drug: L-NMMA;   Drug: Bradykinin;   Drug: Nitroprusside;   Drug: S-methyl-L-thiocitrulline (SMTC);   Drug: Acetylcholine
26 Recruiting Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C
Condition: Hyperlipidemia
Intervention:
27 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)
28 Unknown  Risk Assessment of Long-Haul Truck Drivers
Conditions: Gonorrhea;   Chlamydia Infections;   Hepatitis B;   Hepatitis C;   Diabetes Mellitus;   Hypertension;   Obesity;   HIV Infections;   Hyperlipidemia
Intervention:
29 Recruiting Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
Condition: Primary Hyperlipidemia and Mixed Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Drug: Atorvastatin;   Drug: Placebo
30 Recruiting Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin in Mixed Hypercholesterolemic Patient(CKD-337)
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 20mg;   Drug: Fenofibrate 160mg;   Other: Placebo (Fenofibrate 160 mg)
31 Recruiting to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
Condition: HbA1c Level Associated With Lipid Compositions
Interventions: Drug: Pitavastatin calcium 4mg;   Drug: Pitavastatin calcium 2mg
32 Recruiting RCT Examining Effects of Probiotics in T2DM Individuals
Conditions: Type 2 Diabetes Mellitus;   Obesity;   Hypertension;   Hyperlipidemia
Interventions: Dietary Supplement: Probiotic;   Dietary Supplement: Placebo
33 Unknown  Cardiovascular Health And Risk Modification in Family Health Teams
Conditions: Cardiovascular Risk Factors;   Hypertension;   Hyperlipidemia;   Diabetes
Intervention: Behavioral: Active risk factor surveillance
34 Recruiting The Health Access and Recovery Peer Program
Conditions: Hypertension;   Arthritis;   Coronary Artery Disease;   Hepatitis;   Diabetes;   Asthma;   Hyperlipidemia;   HIV
Intervention: Behavioral: HARP Intervention
35 Recruiting Prioritized Clinical Decision Support to Reduce Cardiovascular Risk
Conditions: Hypertension;   Hyperlipidemia;   Diabetes;   Smoking
Intervention: Behavioral: Prioritized Clinical Decision Support
36 Unknown  Standard Process 21 Day Purification Program Project
Condition: Hyperlipidemia
Intervention: Other: Standard Process 21 Day Purification Program (SPPP)
37 Unknown  Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
Conditions: Hypertension;   Hyperlipidemia;   Hyperglycemia;   Cardiovascular Disease;   Smoking
Intervention: Behavioral: Cardiovascular risk factors and willingness to change
38 Unknown  Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
Conditions: Healthy;   Metabolic Syndrome X;   Hyperlipidemia;   Hypertension;   Diabetes Mellitus
Intervention:
39 Recruiting Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3
Condition: Hyperlipidemia
Interventions: Drug: Part A, Atorvastatin;   Other: Part A, Placebo (administered orally);   Drug: Part B, Evolocumab;   Other: Part B, Placebo (administered orally);   Drug: Part B, Ezetimibe;   Other: Part B, Placebo (administered subcutaneously);   Drug: Part C, Evolocumab
40 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure)
Intervention: Drug: Ampicillin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years